EU Mobile App For Reporting ADRs To Be Tested In Burkina Faso And Zambia

An app for reporting adverse drug reactions developed by Europe’s Innovative Medicines Initiative is being tested in two African countries, where the mobile infrastructure is said to be more advanced than in EU. The app is expected to help in the collection of ADR data from malaria programs and from general medicines use.

More from Drug Safety

More from Pink Sheet